Health Canada inspection
GlaxoSmithKline Pharmaceuticals S.A.: Health Canada inspection of Apr 28, 2017
Health Canada · GMP · rating C
Key facts
| Establishment | GlaxoSmithKline Pharmaceuticals S.A. |
|---|---|
| City | Poznan |
| Country | Poland |
| Program | GMP |
| Start date | Apr 28, 2017 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.